Results
13
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
13 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
SRAIL New | CHF 18.92 | -15.7% | -43.4% | CHF 1.9b | CHF 21.54 | PE15.4x | E22.9% | 4.8% | Capital Goods | ||
EMMN | CHF 779.00 | -4.2% | -12.1% | CHF 4.2b | CHF 1,000.25 | PE21.6x | E13.0% | 2.0% | Food, Beverage & Tobacco | ||
BAER | CHF 53.08 | -1.2% | 10.2% | CHF 10.9b | CHF 58.16 | PE29.1x | E22.4% | 4.9% | Diversified Financials | ||
DOKA | CHF 674.00 | -2.0% | 46.4% | CHF 2.8b | CHF 633.43 | PE66.9x | E35.0% | 1.2% | Capital Goods | ||
TEMN | CHF 59.50 | -2.9% | -16.1% | CHF 4.3b | CHF 66.55 | PE34.1x | E11.4% | 1.9% | Software | ||
DAE | CHF 133.00 | -4.2% | -31.4% | CHF 2.3b | CHF 177.40 | PE30.8x | E26.3% | 2.4% | Capital Goods | ||
SQN | CHF 334.60 | -1.9% | 68.0% | CHF 5.0b | CHF 310.50 | PE19.4x | E12.6% | 1.3% | Diversified Financials | ||
YPSN | CHF 344.00 | -15.3% | 18.4% | CHF 4.7b | CHF 430.60 | PE63.1x | E40.5% | 0.6% | Healthcare | ||
VACN | CHF 333.70 | -5.9% | -10.9% | CHF 10.0b | CHF 420.53 | PE50x | E21.8% | 1.9% | Capital Goods | ||
CLTN New | CHF 50.40 | -2.3% | -24.4% | CHF 301.2m | CHF 62.50 | PE24.4x | E22.3% | 4.0% | Healthcare | ||
SGSN | CHF 86.74 | -1.0% | 17.3% | CHF 16.2b | CHF 92.94 | PE29.5x | E11.9% | 3.7% | Commercial Services | ||
COTN | CHF 271.00 | -4.2% | 15.0% | CHF 2.1b | CHF 370.71 | PE120.3x | E48.6% | 0.4% | Tech | ||
ALSN | CHF 234.50 | -1.1% | -7.1% | CHF 2.9b | CHF 296.32 | PE27.3x | E26.8% | 1.9% | Tech |